猴痘疫情——在艾滋病流行地区的特考韦瑞马耐药性、管理方法及挑战 - Suppr | 超能文献

相似文献

1

Mpox outbreak-tecovirimat resistance, management approaches, and challenges in HIV-endemic regions.猴痘疫情——在艾滋病流行地区的特考韦瑞马耐药性、管理方法及挑战

Lancet Infect Dis. 2024 Nov;24(11):e672-e673. doi: 10.1016/S1473-3099(24)00591-7. Epub 2024 Sep 10.

2

Tecovirimat for the treatment of severe Mpox in Germany.特考韦瑞用于德国严重猴痘的治疗。

Infection. 2023 Oct;51(5):1563-1568. doi: 10.1007/s15010-023-02049-0. Epub 2023 Jun 5.

3

Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.天花病毒 Tecovirimat 静脉注射制剂的监管审批概述：对天花爆发应对能力的潜在影响，以及 Tecovirimat 的未来开发潜力。

Expert Rev Anti Infect Ther. 2023 Mar;21(3):235-242. doi: 10.1080/14787210.2023.2170350. Epub 2023 Feb 2.

4

Treatment of Mpox with Suspected Tecovirimat Resistance in Immunocompromised Patient, United States, 2022.2022 年美国免疫功能低下患者疑似特考韦瑞玛耐药性猴痘的治疗。

Emerg Infect Dis. 2023 Dec;29(12):2520-2523. doi: 10.3201/eid2912.230849. Epub 2023 Oct 19.

5

Clinical Characteristics and Outcomes of Patients With Mpox Who Received Tecovirimat in a New York City Health System.在纽约市卫生系统中接受特考韦瑞治疗的猴痘患者的临床特征和结局

Open Forum Infect Dis. 2023 Nov 2;10(11):ofad552. doi: 10.1093/ofid/ofad552. eCollection 2023 Nov.

6

Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report.在一名新诊断的患有严重猴痘的HIV患者中，使用西多福韦、牛痘疫苗和延长疗程的特考韦瑞治疗后获得成功结果：一例报告

Vaccines (Basel). 2023 Mar 14;11(3):650. doi: 10.3390/vaccines11030650.

7

Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak : A Retrospective Cohort Study.特考韦瑞玛治疗 2022 年猴痘疫情期间的 HIV 感染者：一项回顾性队列研究。

Ann Intern Med. 2023 May;176(5):642-648. doi: 10.7326/M22-3132. Epub 2023 May 2.

8

Pharmacokinetics of tecovirimat in subjects with Mpox.特考韦瑞在猴痘患者中的药代动力学。

Int J Antimicrob Agents. 2024 Feb;63(2):107068. doi: 10.1016/j.ijantimicag.2023.107068. Epub 2023 Dec 22.

9

Implementation and early outcomes of a telehealth visit model to deliver tecovirimat for mpox infection in New York City.纽约市用于提供替考韦瑞马特治疗猴痘感染的远程医疗就诊模式的实施及早期结果

J Telemed Telecare. 2025 May;31(4):534-539. doi: 10.1177/1357633X231194796. Epub 2023 Aug 25.

10

Successful Distribution of Tecovirimat During the Peak of the Mpox Outbreak - Los Angeles County, June 2022-January 2023.2022 年 6 月-2023 年 1 月，猴痘疫情高峰期时特考韦瑞玛特的成功分发 - 洛杉矶县。

MMWR Morb Mortal Wkly Rep. 2024 Jun 20;73(24):546-550. doi: 10.15585/mmwr,mm7324a2.

引用本文的文献

1

A Severe Form of Mpox Infection and the Current Epidemiological Status in Romania.罗马尼亚的一种严重形式的猴痘感染及当前流行病学状况。

Microorganisms. 2025 Aug 3;13(8):1814. doi: 10.3390/microorganisms13081814.

2

Harnessing Nanohybridized Niclosamide for Precision Mpox Therapeutics.利用纳米杂交氯硝柳胺实现精准猴痘治疗

Adv Healthc Mater. 2025 May;14(14):e2404818. doi: 10.1002/adhm.202404818. Epub 2025 Feb 23.

3

An urgent call to address the intersection of mpox and HIV in Africa.应对非洲猴痘与艾滋病毒交叉问题的紧急呼吁。